144 related articles for article (PubMed ID: 3318280)
21. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M; McGarry R; Kupelnick B
Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
[TBL] [Abstract][Full Text] [Related]
22. Recurrency rate influencing effect on intravesical Lycurim treatment in transurethrally resected bladder tumours.
Kondás J; Szentgyörgyi E
Ther Hung; 1983; 31(2):55-8. PubMed ID: 6571182
[No Abstract] [Full Text] [Related]
23. [Treatment of bladder tumors].
Njinou B; Dardenne B; Darimont M; Wese FX; Van Cangh PJ
Acta Urol Belg; 1999; 67(1):6-10. PubMed ID: 10859816
[No Abstract] [Full Text] [Related]
24. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
25. Intravesical antineoplastic therapy following transurethral resection of bladder tumors: nursing implications from the operating room to discharge.
Washburn DJ
Clin J Oncol Nurs; 2007 Aug; 11(4):553-9. PubMed ID: 17723968
[TBL] [Abstract][Full Text] [Related]
26. [Intravesical adjuvant chemotherapy for superficial bladder cancer -- results of a survey in Saxony].
Steinbach F; Schuster F
Aktuelle Urol; 2005 Aug; 36(4):337-41. PubMed ID: 16110407
[TBL] [Abstract][Full Text] [Related]
27. [An apparatus for intravesical chemotherapy].
Clausen HV; Brems-Dalgaard E
Ugeskr Laeger; 1989 Aug; 151(33):2084-5. PubMed ID: 2773136
[TBL] [Abstract][Full Text] [Related]
28. [Chemotherapy of bladder tumors. Indications and value of loco-regional and systemic application].
Pavone-Macaluso M
Urologe A; 1983 Sep; 22 Suppl():325-31. PubMed ID: 6195795
[TBL] [Abstract][Full Text] [Related]
29. Improving efficacy of intravesical chemotherapy.
Gasión JP; Cruz JF
Eur Urol; 2006 Aug; 50(2):225-34. PubMed ID: 16793196
[TBL] [Abstract][Full Text] [Related]
30. Is intravesical chemotherapy for superficial bladder cancer still justified?
Okeke AA; Probert JL; Gillatt DA; Schwaibold H
BJU Int; 2005 Oct; 96(6):763-7. PubMed ID: 16153195
[No Abstract] [Full Text] [Related]
31. Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
Jakse G
Prog Clin Biol Res; 1985; 185B():69-78. PubMed ID: 3898142
[No Abstract] [Full Text] [Related]
32. [Intravesical chemotherapy in superficial tumors of the bladder].
Lundbeck F
Ugeskr Laeger; 1983 Feb; 145(9):641-4. PubMed ID: 6857826
[No Abstract] [Full Text] [Related]
33. [New therapeutic modalities in invasive bladder tumors].
Reboul F; Vincent P; Plat F; Smires A; Davin JL; Levallois M
Pathol Biol (Paris); 1990 Oct; 38(8):808-9. PubMed ID: 2274365
[No Abstract] [Full Text] [Related]
34. Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?
Weiss C; Wolze C; Engehausen DG; Ott OJ; Krause FS; Schrott KM; Dunst J; Sauer R; Rödel C
J Clin Oncol; 2006 May; 24(15):2318-24. PubMed ID: 16710030
[TBL] [Abstract][Full Text] [Related]
35. Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.
Huncharek M; Kupelnick B
Am J Clin Oncol; 2003 Aug; 26(4):402-7. PubMed ID: 12902895
[TBL] [Abstract][Full Text] [Related]
36. Intravesical chemotherapy for superficial bladder tumors category Ta/T1: who should be treated and how?
Kurth KH
Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):30-5. PubMed ID: 8727808
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of non-muscle infiltrating tumours of the bladder].
Irani J
Prog Urol; 2009 Apr; 19(4):248-53. PubMed ID: 19329037
[No Abstract] [Full Text] [Related]
38. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma.
Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H
Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080
[TBL] [Abstract][Full Text] [Related]
39. Re: Willem Oosterlinck,Richard Sylvester, Marco Babjuk, et al. Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors? Eur Urol 2011;59:374-6.
Gudjónsson S
Eur Urol; 2011 Jul; 60(1):e2-3; author reply e4. PubMed ID: 21531071
[No Abstract] [Full Text] [Related]
40. Risk-adapted use of intravesical chemotherapy.
Lerner SP; Au JL
BJU Int; 2008 Nov; 102(9 Pt B):1247-53. PubMed ID: 19035889
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
